Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ANIX

Anixa Biosciences Inc

Jan 16 • 04:00PM ET

2.58

Dollar change +0.30
Percentage change 13.16	%

Healthcare • Biotechnology • USA • NASD

Peers: FATE AFMD INO CYCC ARQT MRKR ADAP KPTI MDGL BNTC

| Held by: VTI VXF IWC DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.39	Insider Own	5.05%	Shs Outstand	32.19M	Perf Week	14.67%
Market Cap	83.07M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	6.07%	Shs Float	30.57M	Perf Month	-9.47%
Income	-12.55M	PEG	-	EPS next Q	-0.09	Inst Own	17.36%	Short Float	1.10%	Perf Quarter	-14.85%
Sales	0.00M	P/S	-	EPS this Y	9.88%	Inst Trans	0.77%	Short Ratio	2.95	Perf Half Y	-18.10%
Book/sh	0.62	P/B	4.15	EPS next Y	34.25%	ROA	-53.29%	Short Interest	0.34M	Perf Year	-48.61%
Cash/sh	0.62	P/C	4.17	EPS next 5Y	-	ROE	-56.63%	52W Range	2.07 - 5.13	Perf YTD	11.21%
Dividend Est.	-	P/FCF	-	EPS past 5Y	7.73%	ROI	-62.15%	52W High	-49.71%	Beta	0.91
Dividend TTM	-	Quick Ratio	8.54	Sales past 5Y	-60.00%	Gross Margin	-	52W Low	24.64%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	8.54	EPS Y/Y TTM	-24.28%	Oper. Margin	-	RSI (14)	50.97	Volatility	9.83% 7.47%
Employees	5	Debt/Eq	0.01	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	8.50
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-3.58%	Payout	-	Rel Volume	1.68	Prev Close	2.28
Sales Surprise	-	EPS Surprise	-29.41%	Sales Q/Q	-	Earnings	Jan 01	Avg Volume	113.85K	Price	2.58
SMA20	5.48%	SMA50	-10.74%	SMA200	-13.13%	Trades		Volume	188,210	Change	13.16%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-23-22	Initiated	Chardan Capital Markets	Buy	$8
Apr-12-21	Initiated	H.C. Wainwright	Buy	$11

Dec-06-24 08:30AM	iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 (ACCESS Newswire)
Dec-04-24 08:30AM	Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 (PR Newswire)
Nov-22-24 08:15AM	Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset (PR Newswire)
Nov-18-24 08:20AM	Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Nov-08-24 01:17PM	Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
08:30AM	Loading…
Nov-06-24 08:30AM	Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
Oct-31-24 08:15AM	Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024 (PR Newswire)
Oct-28-24 08:30AM	Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire) +22.15%
Oct-16-24 05:42AM	Anixa Biosciences administers second CAR-T dose in ovarian cancer trial (Clinical Trials Arena)
Oct-15-24 09:00AM	Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Oct-07-24 08:30AM	Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development (PR Newswire)
Sep-30-24 08:30AM	Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial (PR Newswire)
Sep-25-24 04:52AM	Anixa announces plans to launch Phase II breast cancer vaccine trial (Clinical Trials Arena) -6.80%
Sep-24-24 08:30AM	Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine (PR Newswire)
Sep-18-24 08:30AM	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference (PR Newswire)
08:30AM	Loading…
Sep-03-24 08:30AM	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium (PR Newswire)
Aug-26-24 08:30AM	Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +6.29%
Jul-29-24 08:45AM	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting (PR Newswire)
Jul-23-24 08:15AM	Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy (PR Newswire) -7.67%
07:45AM	EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy (Benzinga)
Jul-17-24 08:00AM	Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology (PR Newswire)
Jul-15-24 08:30AM	Anixa Biosciences Announces $5 Million Share Repurchase Program (PR Newswire) +16.25%
08:00AM	EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program (Benzinga)
Jun-24-24 08:45AM	Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Jun-04-24 09:52PM	ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 (InvestorPlace)
May-28-24 06:10AM	7 Penny Biotech Stocks to Triple Your Investment (InvestorPlace)
May-21-24 07:30AM	Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
May-09-24 04:21AM	Anixa expands cancer vaccine collaboration with Cleveland Clinic (Pharmaceutical Technology)
May-08-24 08:25AM	Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines (PR Newswire)
May-07-24 09:15AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
08:05AM	Loading…
May-06-24 08:05AM	Anixa Biosciences CEO Featured on 'Target: Cancer Podcast' by Oncologist Dr. Sanjay Juneja (PR Newswire)
Apr-30-24 07:45AM	Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 (PR Newswire)
Apr-18-24 08:20AM	Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board (PR Newswire)
Mar-14-24 08:45AM	Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties (PR Newswire)
Mar-11-24 08:00AM	Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress (PR Newswire)
Feb-12-24 07:30AM	Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Jan-29-24 08:50AM	Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference (PR Newswire)
Jan-23-24 07:55AM	Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
Jan-16-24 08:47AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE) +14.35%
Jan-10-24 09:00AM	Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024 (PR Newswire) +9.11%
Dec-14-23 07:15AM	Anixa Biosciences to Present at Biotech Showcase 2024 (PR Newswire)
Dec-11-23 12:26PM	3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 (InvestorPlace)
Dec-06-23 06:00PM	Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine (PR Newswire) -8.40%
04:05PM	Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine (PR Newswire)
Nov-27-23 08:30AM	Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
Oct-31-23 08:30AM	Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference (PR Newswire)
Oct-30-23 07:38AM	Dr. Reddy's (RDY) Q2 Earnings and Revenues Beat Estimates (Zacks)
Oct-23-23 08:30AM	Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board (PR Newswire)
Oct-20-23 05:36AM	Bristol Myers' (BMY) Opdivo SC Meets Kidney Cancer Study Goals (Zacks)
Oct-13-23 09:55AM	Bears are Losing Control Over ANIXA BIOSCIENCES INC (ANIX), Here's Why It's a 'Buy' Now (Zacks)
08:30AM	Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Oct-12-23 11:08AM	BioCardia (BCDA) Up on Plans for Second Heart Failure Study (Zacks)
Oct-03-23 08:30AM	Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology (PR Newswire)
Sep-21-23 12:00PM	ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-19-23 08:30AM	Anixa Biosciences Establishes Cancer Business Advisory Board (PR Newswire) +5.62%
Sep-11-23 10:11PM	The 3 Most Undervalued Cheap Stocks to Buy in September 2023 (InvestorPlace)
Aug-31-23 08:30AM	Anixa Biosciences to Participate in September Investor Conferences (PR Newswire)
Aug-28-23 08:30AM	Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Aug-14-23 08:30AM	Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit (PR Newswire)
Aug-10-23 09:30AM	Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer? (ACCESSWIRE)
Aug-07-23 08:30AM	Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial (PR Newswire)
Jul-27-23 08:30AM	Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
Jul-24-23 10:44AM	Gilead (GILD) Ends Myelodysplastic Syndromes Study on Magrolimab (Zacks)
Jul-21-23 12:05PM	Vir Biotechnology (VIR) Down on Influenza Study Failure (Zacks)
Jul-14-23 10:56AM	Halozyme (HALO) Rises 5% as Ocrevus SC Meets Goals in MS Study (Zacks) +14.47%
Jul-13-23 07:08AM	AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46% (Zacks)
Jul-11-23 10:24AM	Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30% (Zacks) +7.02%
08:30AM	Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology (PR Newswire)
Jul-07-23 10:42AM	ASLAN (ASLN) Down 25% on Mixed Results From Skin Disease Study (Zacks)
Jun-22-23 12:00PM	What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock (Zacks)
May-22-23 08:30AM	Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Apr-25-23 09:40AM	Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year? (Zacks) -5.71%
Apr-18-23 11:43AM	Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data (Zacks)
Apr-17-23 03:27PM	Anixa Biosciences Clarifies Poster Presentation on Company Website (PR Newswire) -24.46%
01:35PM	Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine (PR Newswire)
Apr-14-23 08:50AM	Here's What Could Help ANIXA BIOSCIENCES INC (ANIX) Maintain Its Recent Price Strength (Zacks)
Apr-03-23 08:47AM	We're Interested To See How Anixa Biosciences (NASDAQ:ANIX) Uses Its Cash Hoard To Grow (Simply Wall St.) +9.30%
Mar-27-23 08:30AM	Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting (PR Newswire) +6.19%
Mar-13-23 08:30AM	Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank (PR Newswire)
Mar-02-23 08:30AM	Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders (PR Newswire)
Feb-27-23 08:30AM	Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology (PR Newswire) +7.95%
Feb-21-23 08:30AM	Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board (PR Newswire)
Jan-24-23 07:59AM	Are Investors Undervaluing Anixa Biosciences, Inc. (NASDAQ:ANIX) By 38%? (Simply Wall St.)
Dec-28-22 10:39AM	12 Best Biotech Stocks to Buy Under $10 (Insider Monkey)
06:11AM	Anixa Biosciences, Inc. (NASDAQ:ANIX): Is Breakeven Near? (Simply Wall St.)
Dec-19-22 08:30AM	Anixa Biosciences to Present at Biotech Showcase 2023 (PR Newswire)
Dec-08-22 08:30AM	Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine (PR Newswire) -5.52%
Nov-08-22 08:30AM	Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium (PR Newswire)
Oct-31-22 08:30AM	Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy (PR Newswire)
Oct-26-22 08:30AM	Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic (PR Newswire) +10.46%
Oct-25-22 07:51AM	Anixa Biosciences (NASDAQ:ANIX) Is In A Strong Position To Grow Its Business (Simply Wall St.)
Oct-10-22 08:30AM	Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
Sep-12-22 08:30AM	Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium (PR Newswire) +8.70%
Aug-31-22 08:30AM	Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference (PR Newswire)
Aug-15-22 08:30AM	Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire) +12.07%
Jul-21-22 08:30AM	Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology (PR Newswire) +8.36%
Jun-21-22 08:30AM	Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology (PR Newswire)
May-18-22 06:16AM	Anixa Biosciences (NASDAQ:ANIX) Is In A Strong Position To Grow Its Business (Simply Wall St.)
May-05-22 08:30AM	Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference (PR Newswire) -9.34%
May-02-22 09:40AM	Has Anixa Biosciences (ANIX) Outpaced Other Medical Stocks This Year? (Zacks)

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KUMAR AMIT	Chief Executive Officer	Jan 15 '25	Buy	2.23	43,000	95,890	559,925	Jan 15 01:15 PM
Catelani Michael	President, COO, & CFO	Jan 15 '25	Buy	2.15	9,289	19,971	44,500	Jan 15 12:48 PM
Titterton Lewis H jr	Director	Oct 22 '24	Option Exercise	2.58	16,000	41,200	912,334	Oct 23 11:27 AM
Titterton Lewis H jr	Director	Jul 30 '24	Buy	3.06	21,646	66,237	890,754	Aug 01 12:42 PM
Titterton Lewis H jr	Director	Jul 31 '24	Buy	3.23	5,580	18,023	896,334	Aug 01 12:42 PM
Titterton Lewis H jr	Director	Jul 26 '24	Buy	3.03	7,700	23,331	869,108	Jul 29 06:05 AM
Titterton Lewis H jr	Director	Jul 25 '24	Buy	2.81	796	2,237	861,408	Jul 29 06:05 AM
Baskies Arnold M	Director	Jul 26 '24	Buy	3.09	5,000	15,450	115,000	Jul 26 01:26 PM
Titterton Lewis H jr	Director	Jun 14 '24	Buy	2.68	4,000	10,720	860,612	Jun 18 09:22 AM
Titterton Lewis H jr	Director	Jun 13 '24	Buy	2.70	405	1,094	856,612	Jun 14 09:56 AM
Titterton Lewis H jr	Director	Jun 11 '24	Buy	2.66	7,102	18,891	856,207	Jun 12 11:18 AM
Titterton Lewis H jr	Director	Jun 10 '24	Buy	2.60	330	858	849,105	Jun 12 11:18 AM
Titterton Lewis H jr	Director	Jun 07 '24	Buy	2.52	10,738	27,060	848,775	Jun 10 10:03 AM
Catelani Michael	President, COO, & CFO	Jun 07 '24	Buy	2.40	6,250	15,000	35,211	Jun 07 12:24 PM
KUMAR AMIT	Chief Executive Officer	Jun 07 '24	Buy	2.41	25,000	60,250	516,925	Jun 07 10:57 AM
Titterton Lewis H jr	Director	Apr 09 '24	Buy	3.28	15,009	49,230	838,037	Apr 10 09:44 AM
Baskies Arnold M	Director	Mar 15 '24	Buy	3.63	10,000	36,300	110,000	Mar 15 02:15 PM
KUMAR AMIT	Chief Executive Officer	Mar 15 '24	Buy	3.22	30,000	96,600	491,925	Mar 15 10:49 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANIX

Anixa Biosciences Inc

Upgrade your FINVIZ experience